Novartis pays $12B for Avidity and its RNA therapy platform
Novartis Acquires Avidity Biosciences for $12 Billion Novartis has agreed to acquire Avidity Biosciences in a deal worth $12 billion, aiming to accelerate the development of late-stage tre…
Novartis Acquires Avidity Biosciences for $12 Billion Novartis has agreed to acquire Avidity Biosciences in a deal worth $12 billion, aiming to accelerate the development of late-stage tre…
Record Job Cuts at Amazon and UPS Amazon has announced plans to lay off around 14,000 employees, marking another round of cost-cutting. Th…
Animal Crossing: New Horizons Update and Switch 2 Edition A major free update for Animal Crossing: New Horizons is set to arrive in Januar…
Sentinel-1D Ready for Launch in November The Sentinel-1D satellite is set to launch on November 4 at 6:03 PM local time in Kourou (10:03 P…
Human-Centric AI: Bridging Care Gaps and Easing Hospital Strain Health systems across the United States are facing a daunting reality: a p…
VisitMalta Wins Gold At US Travel Awards For Second Year In A Row Malta has scored big once again on the international travel stage. Visit…
Alex Eala Exits Hong Kong Open Alex Eala and Victoria Mboko faced off in the round of 16 at the Hong Kong Open, both showing signs of exha…
NewJeans Loses Court Battle to Leave Agency K-pop group NewJeans has lost their court battle against management agency Ador, according to …
Integra Stock Dips on Lowered Guidance After Q3 Sales Miss Integra LifeSciences (Nasdaq: IART) shares fell after reporting third-quarter r…
Baxter Stock Slides After Q3 Sales Disappoint Baxter (NYSE: BAX) shares dropped over 16% to $18.82 in early trading due to third-quarter r…
Trump's Authoritarian Threats Spark Criticism President Donald Trump has made a shocking claim that he could deploy the Navy, Air Force, a…